FDA update news from FiercePharma
News
The FDA's surprising plea for cash
Finally, FDA chief Andrew von Eschenbach is crying uncle. After weeks of pressure from Congress to request more money for the agency--and weeks of Read more...
Public Citizen joins FDA review
When Cephalon asked the FDA to expand the use of its opioid painkiller Fentora, did it see the shape of things to come at the Read more...
How the FDA will spend your fees
Curious how the FDA might spend its PDUFA fees? A new five-year plan shows that FDA will plow the money into post-marketing safety to meet its commitments under the new law passed last fall. The Read more...
FDA aims to hire 1,300 by October
In answer to its critics, FDA is mounting a major hiring push to expand its drug safety operations. By October, it hopes to add 1,300 to its payroll--600 new positions and 700 vacancies that have Read more...
FDA wants power to police imports
The FDA finally put its mouth where the money is. During congressional hearings yesterday, CDER chief Read more...
FDA: Drugmakers responsible for safety
Congress may be all fired up about funding more foreign inspections by the FDA, but the agency itself? Not so much. In Read more...
FDA Commish chided over import safety
FDA Commissioner Andy von Eschenbach found himself in the hot seat again at a Congressional Read more...
Industry Voices: Reading the tea leaves at the FDA
Mark Senak is the author of the blog Eye On FDA When lava flows from an island volcano--and when an extensive eruption is over with--the island will be Read more...
Dems pitch big safety bill
It was inevitable: All the chit-chat about drug safety and the FDA's shortcomings had to result Read more...
FDA's China office opens next month
FDA watchdogs will move into China next month, HHS Secretary Mike Leavitt said. The agency's Chinese office signals a new approach toward food and drug safety, he said; it's too tough to Read more...
Get more FDA update coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight